2023
PO77 Dwell Position Sequencing: A Clinically-Viable Approach to Modify Biological Dose in High-Dose-Rate Brachytherapy?
Tien C, Carlson D. PO77 Dwell Position Sequencing: A Clinically-Viable Approach to Modify Biological Dose in High-Dose-Rate Brachytherapy? Brachytherapy 2023, 22: s107. DOI: 10.1016/j.brachy.2023.06.178.Peer-Reviewed Original Research
2015
SU‐E‐T‐523: Investigation of Various MR‐Compatible Shielding Materials for Direction Modulated Brachytherapy (DMBT) Tandem Applicator for Cervical Cancer Treatment
Safigholi H, Han D, Soliman A, Meigooni A, Scanderbeg D, Song W. SU‐E‐T‐523: Investigation of Various MR‐Compatible Shielding Materials for Direction Modulated Brachytherapy (DMBT) Tandem Applicator for Cervical Cancer Treatment. Medical Physics 2015, 42: 3455-3455. DOI: 10.1118/1.4924885.Peer-Reviewed Original ResearchDirection modulated brachytherapyShielding materialsPlan qualityLevels of intensity modulationClinical patient plansClinical plan qualityCervical cancer brachytherapyOAR D2ccDose matrixPrescription doseSigmoid D2ccPatient plansMonte Carlo simulationsCancer brachytherapyHRCTV D90Rectum D2ccHDR brachytherapyIntensity modulationD2ccPlanning systemCarlo simulationsAuCervical cancer treatmentHRCTVMR compatibility
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply